CarcinoX: A Novel Ultra-Nano Inverse Entity (UNIE)–Based Preventive and Risk-Modulatory Intervention Platform for Cancer Susceptibility Reduction
Fuente:
Zenodo
Salvato in:
| Autore principale: | |
|---|---|
| Natura: | Recurso digital |
| Lingua: | inglese |
| Pubblicazione: |
Zenodo
2026
|
| Soggetti: | |
| Accesso online: | |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
| _version_ | 1866901212017721344 |
|---|---|
| author | Ray, Sumeru |
| author_facet | Ray, Sumeru |
| contents | <p dir="ltr">CarcinoX is a newly developed preventive and cancer risk-modulatory intervention platform engineered using Ultra-nano Inverse Entities (UNIEs)—non-biological, ultra-refined, physicochemically inverted nano-scale constructs derived from carefully processed pathology-associated cellular templates. These templates originate from malignant-state substrates, deep-seated etiological micro-disruption sources, and toxico-metabolic alteration residues.</p> <p dir="ltr">Through a multi-stage transformation process designed to completely eliminate all biological identity, the original templates are converted into bio-inert, stable, inverse-pattern ultra-nano entities that embody physicochemical signatures opposing malignant and pre-malignant cellular deviations. UNIEs are designed to selectively interact with dysregulated or cancer-prone cellular environments, neutralizing malignant drift and supporting the restoration of regulated physiological behavior—while leaving healthy tissues unaffected.</p> <p dir="ltr">As the final construct contains no viable cells, no genetic material, no chemical agents, and no biological residues, CarcinoX represents an exceptionally safe, non-toxic, and non-immunogenic intervention. This paper presents the scientific rationale, conceptual preparation framework, mechanistic basis, and core inverse-signature principles that define CarcinoX as a first-in-class, globally scalable, biologically inert preventive platform for reducing malignant susceptibility and stabilizing cellular regulatory behavior.</p> |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_18210896 |
| institution | Zenodo |
| language | eng |
| publishDate | 2026 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | CarcinoX: A Novel Ultra-Nano Inverse Entity (UNIE)–Based Preventive and Risk-Modulatory Intervention Platform for Cancer Susceptibility Reduction Ray, Sumeru Cancer Vaccine <p dir="ltr">CarcinoX is a newly developed preventive and cancer risk-modulatory intervention platform engineered using Ultra-nano Inverse Entities (UNIEs)—non-biological, ultra-refined, physicochemically inverted nano-scale constructs derived from carefully processed pathology-associated cellular templates. These templates originate from malignant-state substrates, deep-seated etiological micro-disruption sources, and toxico-metabolic alteration residues.</p> <p dir="ltr">Through a multi-stage transformation process designed to completely eliminate all biological identity, the original templates are converted into bio-inert, stable, inverse-pattern ultra-nano entities that embody physicochemical signatures opposing malignant and pre-malignant cellular deviations. UNIEs are designed to selectively interact with dysregulated or cancer-prone cellular environments, neutralizing malignant drift and supporting the restoration of regulated physiological behavior—while leaving healthy tissues unaffected.</p> <p dir="ltr">As the final construct contains no viable cells, no genetic material, no chemical agents, and no biological residues, CarcinoX represents an exceptionally safe, non-toxic, and non-immunogenic intervention. This paper presents the scientific rationale, conceptual preparation framework, mechanistic basis, and core inverse-signature principles that define CarcinoX as a first-in-class, globally scalable, biologically inert preventive platform for reducing malignant susceptibility and stabilizing cellular regulatory behavior.</p> |
| title | CarcinoX: A Novel Ultra-Nano Inverse Entity (UNIE)–Based Preventive and Risk-Modulatory Intervention Platform for Cancer Susceptibility Reduction |
| topic | Cancer Vaccine |
| url | https://doi.org/10.5281/zenodo.18210896 |